|
|
Mentors
for the Psychiatry Research Track
Kenneth Kendler, M.D.
Distinguished Professor of
Psychiatry
Professor of Human Genetics
Director, Virginia Institute for Psychiatric and Behavioral
Genetics
Research
Areas:
- Genetics of Schizophrenia, Alcoholism,
Anxiety Disorders, Depression, and
Drug Abuse
Major Recent/Current Grants:
- NIDA: A Twin-Family Study of Drug
Use, Abuse, and Dependence
- NIH/NRSA: Research Training: Psychiatric
and Statistical Genetics
- NIH/NIMH: Epidemiology of Mood,
Anxiety, and Alcohol Disorders
- NIH/NIMH: Parental Effects on Depression
and Disruptive Behavior in Children of Twins
- NIMH/NIAAA: An Irish Affected Sib
Pair Study of Alcohol Dependence
- NIH/NIMH: Transmission of Vulnerability
Factors for Schizophrenia
- NIMH: Familial Psychiatric Disorder
& Attention in Schizophrenia
- NIH: Psychopathology: Models, Measurement,
and Classification
- NIMH: Axis I and II Psychiatric
Disorders in Norwegian Twins
- NIMH: Multicenter Genetic Studies
of Schizophrenia
- NIMH: The Genetic Epidemiology of
Schizophrenia in Ireland
Page
on Website of VIPBG
Pub
Med Listings
Michael C Neale, Ph.D.
Professor of Psychiatry
Professor of Human Genetics
Professor of Statistical Methods for Behavioral Genetics
Associate Director, Virginia Institute for Psychiatric and
Behavioral Genetics
Research Areas:
- Statistical Modeling for Behavioral
Genetics and Neuroimaging
- Psychometrics and Nosology of Psychiatric
Disorders and Substance Abuse
- Genetics of all Major Psychiatric
Disorders, Substance Use and Abuse
Major Recent/Current Grants:
- NIH/NRSA: Research Training: Psychiatric
and Statistical Genetics
- NIH/NIMH: Psychopathology: Models,
Measurement and Classification
- NIH/NIDA: Psychometrics and Genetic
Assessments of Substance Use
- NIH/NIDA: A Twin-Family Study of
Drug Use, Abuse, and Dependence
- NIH/NIMH: Axis I and II Psychiatric
Disorders in Norwegian Twins
Page
on Website of VIPBG:
Pub
Med Listings
John Hettema, M.D., Ph.D.
Associate Professor of Psychiatry
Virginia Institute for Psychiatric and Behavioral Genetics
Department of Psychiatry, Virginia Commonwealth University
Research Areas:
- Genetic epidemiology and molecular
genetics of anxiety disorders and depression
Major Recent/Current Grants:
- NIH/NIMH Mentored Clinical Scientist
Development Award: Genetics of Fear
and Anxiety Disorders (2002-07)
- VCU A.D. Williams Grant (PI): Candidate
Genes in Anxiety Disorders (2005-07)
- NIMH (PI): Identification of Susceptibility
Genes for the Anxiety Disorders (2007-08)
- NIMH (PI-subcontract): The Classification
of Anxiety and Mood Disorders (2007-12)
Page
on Website of VIPBG
Pub
Med Listings
Susan Kornstein, M.D.
Professor of Psychiatry and Obstetrics/Gynecology
Affiliate Clinical Professor of Psychology
Executive Director, Institute for Women's Health, a DHHS National
Center of Excellence in Women’s Health
Executive Director, Mood Disorders Institute
Director of Clinical Research, Department of Psychiatry
Research Areas:
- Clinical Drug Trials, Depression,
Women's Mental Health
Major Recent/Current Grants:
- NIMH: Symptom-Onset Antidepressant
Treatment for Premenstrual Dysphoric Disorder
- NIMH: Depression Trials Network
- NIMH: STAR*D Regional Center
- DHHS: National Center of Excellence
in Women’s Health
- Lilly: Duloxetine versus Placebo
in Patients with Major Depressive Disorder (MDDD): Assessment
of Energy and Vitality
- Bristol-Myers Squibb: Multi-Center,
Randomized, Double-Blind, Placebo-Controlled Trial of the
Safety and Efficacy of Pexacerfont BMS-560286 in the Treatment
of Outpatients with Generalized Anxiety Disorder
- Novartis: Multicenter, Randomized,
Double-Blind, Placebo- and Paroxetine-Controlled Study of
the Efficacy, Safety, and Tolerability of Agomelatine 25
or 50 mg Given Once Daily for Major Depressive Disorder
- Boehringer Ingelheim: 24-Week Randomized,
Double-Blind, Placebo-Controlled Safety and Efficacy Trial
of Flibanserin 50 mg Daily and, with Uptitration, 100 mg
Daily inPremenopausal Women with Hypoactive Sexual Desire
Disorder
- Forest Laboratories: A Fixed Dose
Comparison of Escitalopram to Active Comparator in Moderately-to-Severely
Depressed Patients
- Wyeth: A Multicenter, Randomized,
8-Week, Double-Blind Acute Phase Followed by a 6-Month Continuation
Phase (Open-Label or Double-blind) Study to Evaluate the
Efficacy, Safety, and Tolerability of DVS SR in Postmenopausal
Women with Major Depressive Disorder
- Wyeth: A Multicenter, Randomized,
8-Week, Double-Blind, Placebo-Controlled Study Followed
by a 6-Month Open-Label Extension to evaluate the Efficacy
and Safety of DVS SR in Peri- and Postmenopausal Women with
Major Depressive Disorder
Mood Disorders
Institute
Institute
for Women’s Health
Link
to Pub Med Listings
Robert Balster, Ph.D.
Butler Professor of Pharmacology and Toxicology
Affiliate Professor of Psychiatry and Psychology
Director, Institute for Drug and Alcohol Studies
Research Areas:
- Neurobehavioral Basis of Drug Dependence
- Behavioral Pharmacology
- Toxicology,
- Excitatory Amino Acids
- Inhalation Studies
- Health Policy
Major Recent/Current Grants:
- NIDA: Behavioral Pharmacology of
Phencyclidine
- US Department of State: Humphrey
fellowship Program in Substance Abuse Prevention and Treatment
- Virginia Tobacco Settlement Foundation:
Virginia Youth Tobacco Project
- DOV Pharmaceuticals: Drug Discrimination
Study: Cocaine-like Effects in Rats
- DOV Pharmaceuticals: Self-administration
Study in Monkeys
- Forest Laboratories: Self-administration
Study in Rhesus Monkeys
- Forest Laboratories: Self-administration
Study II in Rhesus Monkeys
- NIDA: Discriminative Stimulus Effects
of Abused Inhalants
Department
of Pharmacology and Toxicology
Institute
for Drug and Alcohol Studies
Pub
Med Listings
We will
be periodically listing additional faculty mentors for the
Residency Research Track. Please check back!
|
